June 17 will be an important trading session for these two outperforming stocks
Shares of both Vishal Mega Mart and Sai Life Sciences will be in focus on June 17 as their respective shareholder lock-in period comes to…
Latest News
Peter McGuire sees oil prices cooling, silver heating up
The CEO of Trading.com sees industrial metals, precious metals, and energy markets moving on a mix of macroeconomic shifts, supply changes, and geopolitical developments.
Gold rates rise in India on global cues; investors eye US jobs data for direction
According to GoodReturns, 24 karat gold climbed ₹430 to ₹99,600 per 10 grams, while 22 karat gold rose ₹400 to ₹91,300 per 10 grams.
AI disruption will come fast, and IT may rally with it: Sowilo’s Agarwal
Sandip Agarwal of Sowilo Investment Managers sees AI-driven change as both a challenge and an opportunity. While the sector may currently be in a holding…
Railtel Corporation shares gain 4% on bagging ₹274 crore order
The estimated order size is ₹274.40 crore. The final contract value will be confirmed upon issuance of the Purchase Order (PO), the company said in…
Market Holiday: Are NSE, BSE open or closed on June 6 on account of Eid al-Adha?
According to the official holiday calendars of both the National Stock Exchange (NSE) and the BSE, there will be no trading holiday on Friday, June…
Coforge is an ‘all-weather growth champion’; JPMorgan projects 20% upside
JPMorgan has named Coforge as its top pick in the Indian IT space, backed by multiple growth drivers.
Rupee falls 9 paise to 85.96 against US dollar in early trade
At the interbank foreign exchange, the rupee opened at 85.86 and slipped further by 9 paise to 85.96 against the American currency in early trade…
Garden Reach shares surge 4% on MoI with German co for four multi-purpose vessels
GRSE said that it has entered into memorandums of intent and understanding with multiple global partners, marking a strategic move to expand its pipeline beyond…
Dr. Reddy’s Laboratories shares rise after collaboration with Alvotech to make cancer treatment drug
Alvotech and Dr. Reddy’s will collaborate to co-develop a biosimilar candidate to Keytruda (pembrolizumab) for global markets, it said in an exchange filing.